Citation

Collier PN, Twin HC, Knegtel RMA, Boyall D, Brenchley G, Davis CJ, Keily S, Mak C, Miller A, Pierard F, Settimo L, Bolton CM, Chiu P, Curnock A, Doyle E, Tanner AJ, Jimenez JM.: Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis. ACS Med Chem Lett, Volume 10 (8), 2019

Authors

Bolton CM, Boyall D, Brenchley G, Chiu P, Collier PN, Curnock A, Davis CJ, Doyle E, Jimenez JM., Keily S, Knegtel RMA, Mak C, Miller A, Pierard F, Settimo L, Tanner AJ, Twin HC

Journal

ACS Med Chem Lett

Year

2019

DOI

10.1021/acsmedchemlett.9b00134

PubMed

31417666

Machine-readable

REST APIRDF